IGF1 and breast carcinoma: The growth-promoting effects of IGF-1 are mediated primarily through IGF1R, and high cytoplasmic expression of IGF1R in terminal duct lobular units (TDLUs) has been associated with significantly increased risk of later-life breast cancer [15].